InvestorsHub Logo
Followers 4
Posts 74
Boards Moderated 0
Alias Born 01/19/2024

Re: None

Wednesday, 03/27/2024 9:54:17 AM

Wednesday, March 27, 2024 9:54:17 AM

Post# of 47032
Update on the website: RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury March 26, 2024

https://respirerx.com/wp-content/uploads/2024/03/RespireRx-SCI-Bladder-paper-final-approved-for-distribution.pdf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News